Coelho Barata, P. M., Gulati, S., Elliott, A., Rao, A., Burgess, E. F., McKay, R., … Heath, E. (2021). 688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features. In Annals of Oncology (Vol. 32, pp. S705–S705). Elsevier BV. https://doi.org/10.1016/j.annonc.2021.08.084

Coelho Barata, P. M., S. Gulati, A. Elliott, A. Rao, E. F. Burgess, R. McKay, H. J. Hammers, et al. “688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features.” In Annals of Oncology, 32:S705–S705. Elsevier BV, 2021. https://doi.org/10.1016/j.annonc.2021.08.084.

Coelho Barata PM, Gulati S, Elliott A, Rao A, Burgess EF, McKay R, et al. 688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features. In: Annals of Oncology. Elsevier BV; 2021. p. S705–S705.

Coelho Barata, P. M., et al. “688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features.” Annals of Oncology, vol. 32, Elsevier BV, 2021, pp. S705–S705. Crossref, doi:10.1016/j.annonc.2021.08.084.

Coelho Barata PM, Gulati S, Elliott A, Rao A, Burgess EF, McKay R, Hammers HJ, Gartrell B, Darabi S, Bilen MA, Geynisman D, Dawson NA, Poorman K, Zibelman M, Zhang T, Wei S, Korn WM, Nabhan C, Ryan CJ, Heath E. 688P Gene expression profiling (GEP) signatures associated with markers of sensitivity to immune and angiogenic therapy in clear-cell renal cell carcinoma (ccRCC) with sarcomatoid/rhabdoid features. Annals of Oncology. Elsevier BV; 2021. p. S705–S705.